3-tert-butyl-4-hydroxyanisole has been researched along with 2-tert-butylhydroquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishidate, M; Matsui, M; Matsuoka, A; Miyata, N; Sofuni, T | 1 |
| Jones, TW; Lau, SS; Monks, TJ; Peters, MM; Rivera, MI | 1 |
2 other study(ies) available for 3-tert-butyl-4-hydroxyanisole and 2-tert-butylhydroquinone
| Article | Year |
|---|---|
Mutagenicity of 3-tert-butyl-4-hydroxyanisole (BHA) and its metabolites in short-term tests in vitro.
Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Chromosome Aberrations; Cricetinae; Hydroquinones; Mutagenicity Tests; Mutagens; Rats | 1990 |
Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder.
Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Glutathione; Hydroquinones; Kidney; Male; Rats; Rats, Inbred F344; Urinary Bladder; Urogenital Neoplasms | 1996 |